GeneDx Holdings Corp.

NASDAQ (USD): GeneDx Holdings Corp. (WGS)

Last Price

96.57

Today's Change

-0.47 (0.48%)

Day's Change

89.50 - 97.33

Trading Volume

688,391

Profile
WGS

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Ms. Katherine A. Stueland Ms. Katherine A. Stueland

Full Time Employees:  1,000 1,000

IPO Date:  2020-11-04 2020-11-04

CIK:  0001818331 0001818331

ISIN:  US81663L2007 US81663L2007

CUSIP:  81663L200 81663L200

Beta:  2.18 2.18

Last Dividend:  0.00 0.00

Dcf Diff:  148.53 148.53

Dcf:  -53.53 -53.53

Description

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Address

North Tower,
Stamford, CT 06902, US

800 298 6470

http://www.genedx.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment